Pluri Inc. Reports $5.9 Million Loss in Fiscal Q1 2023
Intellectia.AI
2024-11-131mins
Pluri Inc., a biotechnology company based in Haifa, Israel, announced its fiscal first-quarter financial results, revealing a net loss of $5.9 million. This translates to a loss of $1.08 per share. During the same period, the company reported revenue amounting to $326,000. These figures provide insight into the company's current financial health and operational performance.
Share
Want more financial insights delivered directly to your inbox?
Subscribe now and receive handpicked financial news, insights, and trending topics.
Microsoft-Backed Rubrik Set to Launch a $713 Million IPO Amidst Market Rebound
Intellectia.AI2 days ago
Beam Therapeutics Reports Promising Results for BEAM-103 in Sickle Cell Disease
Intellectia.AI17 days ago
Cogent Biosciences Advances Bezuclastinib Trials for Systemic Mastocytosis
Intellectia.AI17 days ago